Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP7 increases the amount of E1B-55K protein. 2 / 2

| 2

➶

reach

"Both USP7 knockdown and inhibitor application severely reduced E1B-55K protein levels, and in the knockdown setting as well as after USP7 inhibitor application the half-life of E1B-55K was significantly shorter (XREF_SUPPLEMENTARY)."

23555268

➶

reach

"Taken together, USP7 knockdown and knockout or inhibition led to greatly reduced E1B-55K protein levels, indicating a stabilizing role of USP7 for E1B-55K."

23555268

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...